Risks and Benefits of Aromatase Inhibitors in Postmenopausal Breast Cancer

Author: Michaud L.B.  

Publisher: Adis International

ISSN: 0114-5916

Source: Drug Safety, Vol.21, Iss.4, 1999-10, pp. : 297-309

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content